Biological effects of low-dose radiation (LDR) are distinguishable from those of high-dose radiation. Hormetic and adaptive responses are such two examples. However, whether adaptive response could be induced in tumor cells by LDR, especially under in vivo condition, remains elusive, and was systemically investigated in the present study. Four tumor cell lines: two human leukemia cell lines (erythroleukemia cell line K562, and acute promyelocytic leukemia cell line HL60), and two human solid tumor cell lines (lung carcinoma cell line NCI-H446 and glioma cell line U251), along with one normal cell line (human fibroblast cells, MRC-5), were irradiated with LDR at 75 mGy of X-rays as D1 and then 4 Gy of X-rays as D2 (i.e.: D1 + D2) or only 4 Gy of X-rays (D2 alone). Three tumor-bearing animal models were also used to further define whether LDR induces adaptive response in tumor cells in vivo. Adaptive response was observed only in normal cell line, but not in four tumor cell lines, in response to LDR, showing a resistance to subsequent D2-induced cell growth inhibition. Three tumor-bearing mouse models with U251, NCI-H446 or S180 tumor cells were used to confirm that pre-exposure of tumor-bearing mice to D1 did not induce the resistance of tumor cells in vivo to D2-induced tumor growth inhibition. Furthermore, a higher apoptotic effect, along with higher expression of apoptosis-related genes P53 and Bax and lower expression of anti-apoptosis gene Bcl-2, was found in tumor cells of the tumor-bearing mice exposed to D1 + D2 than those in the tumor cells of the tumor-bearing mice exposed to D2 alone. These results suggest that LDR does not induce adaptive response in the tumor cells under both in vitro and in vivo conditions, which is a very important, clinic-relevant phenomenon.
INTRODUCTION
Radioadaptive response, as defined by the induction of radioresistance to subsequent high doses of radiation by pretreatment with low-dose radiation (LDR), has been extensively documented by many investigators in different experimental models, including cultured cells and experimental animals. [1] [2] [3] [4] [5] Using splenocytes, thymocytes, bone marrow cells and germ cells we have demonstrated the induction of the radioadaptive response by LDR. 2, 4, 6) However, whether LDR is able to induce radioadaptive response remains dependent on several factors, including cell types. [7] [8] [9] [10] Search on literature reveals that certain tumor cells are resistant to LDR-induced radioadaptive response, or showed a distinct pattern from normal cells for the interval times between LDR and subsequently large dose of radiation. 11, 12) If it true that LDR only induces radioadaptive response in normal cells, but does not in tumor cells, it will be of greatly important since we can manipulate exposure times and doses of LDR in favor of normal tissues, but not of tumor cells, for the induction of radioadaptive response (radioresistance) in cancer patients. Under such condition, the radiotherapeutic efficiency for tumor cells will be able to be enhanced by increasing radiotherapy doses. Therefore, the present study was aimed at systemically determining whether LDR induces adaptive response in tumor cell lines in vitro and in vivo.
METHODS AND MATERIALS

Cell culture
Human small lung cancer cell line (NCI-H446), human glioblastoma cell line (U251), human erythroleukemia cell line (K562), human acute promyelocytic leukemia cell line (HL60) and mouse sarcoma180 cell line (S180) were gifted from Dr. Zhao Lichun, Jilin Provincial Hospital for Cancer. Normal human fetal lung fibroblast (MRC-5) cell line was obtained from Shanghai Biochemical Co. (Shanghai, China). Cells at 2.0 × 10 4 /ml for the attachable cell lines (MRC-5, NCI-H446 and U251) and at 1.0 × 10 4 /ml for floating cell lines (HL60 and K562) were cultured in IMDM medium supplemented with 10% FCS, and incubated in a humidified atmosphere containing 5% CO 2 at 37°C for 12 hr to allow the cells attaching to bottoms of the flasks and then to be exposed to LDR (D1) and high-dose radiation (D2) with different intervals (6 to 72 hr). At the time of these cells exposed to D1, the cell numbers in each flask for each line should be same. After these cells were irradiated (see below), three flasks from each group will be sampled for accounting the total cells at different times (day 1 to 6) after D2 irradiation.
Animals
Both BALB/C-nu/nu (nude) and Kunming mice were purchased from the Animal Center of Chinese Academic Institute (Beijing, China). These mice were housed in the University's Research Resources Center at 22°C with a 12-h light/dark cycle and were provided free access to standard rodent chow and tap water. All animal procedures were approved by the Institutional Animal Case and Use Committee, which is certified by the Chinese Association for Laboratory Animal Care. The first set of animal study was performed using nude mice to produce tumor-bearing mouse models with U251 and NCI-H446 tumor cells. Since these two cell lines were originally derived from human tumors, nude mice lacking immunological response were used to eliminate the reject response to these two tumor cells. For this end, tumor cells were prepared in a concentration of 6 × 10 6 cells/0.2 ml for each mouse in SFM with 1 × antibiotics/antimycotics (Life Technologies, Inc.) and nude mice (23-27g in body weight) were first anesthetized by i.p. injection of ketamine (90-120 mg/kg) plus xylazine (5-10 mg/kg). After fully anesthetized, the animals were implanted subcutaneously in the right hind leg of the mice with 0.2 ml of the U251 or NCI-H446 cell suspension.
Since the first set of animal study was performed using nude mice, whether the same results can be duplicated in normal mice instead of the mice lacking immune response should be tested using a mouse model with normal immune function. Therefore, the second set of animal study was performed using male Kunming mice (23 -27 g in body weight) to produce tumor-bearing model implanted with S180 cells that originally derived from mouse. The procedure was basically same as the above using nude mice, except for 0.2 ml of S180 cell suspension (about 3 × 10 6 cells/ml). When implanted tumor sizes reached about 0.6 -1.0 cm in length, the mice were divided randomly into control (sham), 75 mGy of X-rays as LDR (D1), 10.0 Gy of X-rays as highdose radiation (D2), and D1 + D2 groups, with 10 mice in each group. After exposure to different conditions of radiation, these mice were kept until day 20 with measurements of tumor sizes at different post-implanting times.
Irradiation
For in vitro studies, cultured tumor cells were shamirradiated (Control) or irradiated with D1 (75 mGy), D2 (4 Gy) or D1 + D2 with different times between D1 and D2 (6 to 72 hr) at 37°C. Although it may be different for the radiosensitivity of these tumor cell lines, exposure of NIC-H446 cells to 5 Gy γ-rays caused a significant cytotoxic effect. 13) Given that two leukemia cells may be more sensitive than solid tumor cells, and also a previous study has used 4 Gy of X-rays as D2 to investigate LDR-induced adaptive response in several tumor and normal cell lines in vitro, 9) we decided to use 4.0 Gy as D2 simply for all cells used in the present study in order to easily compare the effects among these cells. For in vivo study, tumor-bearing mice were sham-irradiated (Control) or irradiated in whole body with D1 (75 mGy), D2 (4 Gy for nude mice and 10 Gy for Kunming mice) or D1 + D2 at different interval times (12 -72 hr) between D1 and D2. For the tumor-bearing mouse model with S180 tumor cells, 10 Gy was selected as D2 since Kunming mice is radio-resistant as compared to nude mice. 2, 4, 6) After D2, these tumor-bearing mice were killed on day 20.
For irradiation, a Phillips therapeutic X-ray machine was operated at 200 kVp and 10 mA in the presence of 1 mm Al and 0.5 mm Cu filter plates. The dose rates were 0.05 Gy/ min for D1 and 0.287 Gy/min for D2, respectively. 
Measurement of tumor sizes
TUNEL assay
Tumor tissues from tumor-bearing mice were fixed in 10% formalin, embedded in paraffin, and sectioned at 5 μm. The slides were processed for a TUNEL assay using an ApopTag in situ detection kit from Intergen (Beijing, China) according to the manufacturer's instructions. Briefly, the slides were treated with H2O2 and incubated with the reaction mixture containing TdT and digoxigenin-conjugated dUTP at 37°C for 1 hr. Labeled DNA was visualized with peroxidase-conjugated anti-digoxigenin antibody using 3,3'-diaminobenzidine (DAB) as the chromogen.
In situ hybridization
In situ hybridization kits were purchased from BerShiDe Co. (Wuhan, China) for human p53, Bcl-2 and Bax mRNA. The sequences of these specific probes are below: P53:
(1) 5' -CGAGC TCCCT CTGAG TCAGG AAACA TTTTC -3'
(1) 5' -GATGA AGTAC ATCCA TTATA AGCTG TCGCA -3' (2) 5' -GTCCA GCCAG CTGCA CCTGA CGCCC TTCAC -3' (1) 5' -GTGGA TGACT GAGTA CCTGA ACCGG CACCT -3' Bax:
(1) 5' -CCACC AGCTC TGAGC AGATC ATGAA GACAG -3' (2) 5' -AGGAT GCGTC CACCA AGAAG CTGAG CGAGT -3' (1) 5' -AGCAG AACTG GTGCT CAAGG CCCTG TGCAC -3' Hybridization was performed based on the instruction from the kits. Briefly, 5-μm thick sections were acetylated with 0.25% acetic anhydride in 0.1 M triethalolamine/0.9% NaCl (pH 8), for 10 min at room temperature, dehydrated in ethanol, and hybridized overnight at 50°C with digoxigeninlabeled probes in 200 μl of hybridization buffer (50% formamide, 200 mM NaCl, 2.5 mM EDTA, 10% dextran sulphate, 250 μg/ml yeast tRNA, 50 mM dithiothreitol, and 1 × Denhardt's solution). At the end of the incubation, sections were subjected to consecutive washes in (1) 2 × standard saline citrate (SSC) for 30 min at 60°C; (2) 1 × SSC with 50% formamide for 60 min at 60°C; (3) 0.5 × SSC with 50% formamide for 90 min at 40°C; 0.1 × SSC with 50% formamide for 60 min at 37°C; (4) 0.1 × SSC without formamide for 10 min at room temperature. To visualize digoxigenin-staining, sections were rinsed twice in buffer A (100 mM Tris-HCl/150 mM NaCl, pH 7.5) for 10 min, followed by a 30 min incubation in modified blocking solution (buffer A containing 0.5% bovine serum albumin and 1% blocking reagent) and incubated overnight with the avidin-biotinconjugated antidigoxigenin antiserum (1:500 in modified blocking solution). Sections were consecutively rinsed twice in buffer A for 15 min, in buffer 2 (100 mM Tris-HCl/100 mM NaCl/50 mM MgCl2, pH 9.5) for 3 min. Consecutively sections were incubated at room temperature in the buffer containing DAB and H2O2, as the last step in TUNEL assay.
Immunohistochemical staining
For Bcl-2 and Bax protein expression, tissue sections were deparaffinized in xylen, rehydrated in gradient of alcohol and microwaved for 6 min in 10 mM sodium citrate buffer (pH = 5.5). Subsequently, the slides were incubated for 6 min in peroxidase blocking solution (3% H2O2 in PBS). Slides from experimental and control groups were stained simultaneously under exact conditions. After antigen retrieval, slides were rinsed in distilled water, incubated in 20% sucrose in PBS at 4°C for 30 min, washed in PBS and placed in blocking buffer (3% goat serum in PBS) for 30 min. Then sections were incubated successively with: primary rabbit antiserum overnight; anti-rabbit-biotinylated secondary antibodies (1:200) for 2 hr; and avidin-biotin complex for 30 min. The primary rabbit antibody against human Bcl-2 (1:500) and Bax (1:500) antigens (all from Santa Cruz Biotechnology, Inc., Beijing) were used. The sections were rinsed in PBS and the peroxidase reaction of the avidinbiotin complex was revealed in the buffer containing DAB and hydrogen peroxide. All immunohistochemical reactions were carried out in parallel with reactions lacking primary antibodies to ensure the specificity of the observed staining. Quantification of peroxidase reactions was performed in the linear phase of reaction.
Semi-quantitative analysis
The sections were processed under an established condition for every experiment, which allowed semi-quantitative analysis of mRNA or protein amount on the histological slides. Computer Assist Image system (TV-image and software Videotest) was used for the semi-quantitative analysis. Five sections from each animal were reviewed at 250-fold magnification of a light microscope. Both gene and protein expressions were evaluated by parameters reflecting the expression levels of the gene or protein in selected area: the number of positive cells and the relative optical density of immunopositive substance in the individual cells on every section. Optical density was analyzed by software against the background optical density that was estimated slide in nonimmunoreactive field. Results are presented percentage of the optical density.
Statistical analysis
Results were expressed as mean ± standard deviation. The statistical significance of the differences between groups was evaluated by ANOVA, followed by Student's t-test. Significance was considered at p < 0.05.
RESULTS
Effect of LDR on U251 tumor cells
In the first experiment, total cells were counted for U251 tumor cells and MRC-5 normal cells on day 1 to day 6 after D2 radiation that was given at different times (12 to 72 hr) after D1. Results are summarized in Fig. 1 (Column A for tumor cells), which clearly shows a time-dependent increase in total cells in control and D1 groups. Only a slight increase in the total cells until day 4 with a plateau afterward was observed in D2 alone or D1 + D2 groups regardless interval times. There was no difference between D2 and D1 + D2 groups for the cell numbers of tumor cells. In contrast, adaptive response induced by LDR is significantly evident in MRC-5 normal cells that were exposed to same radiation Fig. 1 . Effects of LDR on subsequent radiation-induced cytotoxic effect. U251 tumor cell line (column A) and MRC-5 normal cell line (column B) were irradiated with 75 mGy of X-rays as D1 and then with 4 Gy of X-rays as D2 at different interval times (indicated in each panel). After D2, these cells were further incubated and harvested at different times on day 1 to day 6 for counting the total cells in each culturing dish. The data are presented as mean ± SD from three dishes at least for each of the three separate experiments. *, p < 0.05 vs control; #, p < 0.05 vs D2 alone.
conditions as U251 cells (Column B in Fig. 1 ). The adaptive response was evident mainly in D1+ D2 groups, i.e. increase in total cells in D1 + D2 groups as compared to that in D2 group.
Effect of LDR on other tumor cell lines
In order to confirm the lack of LDR-induced radioadaptive response in tumor cells, other three tumor cell lines: NCI-H446, K562 and HL60, were also given a D1 (75 mGy) and then D2 (4Gy) at different times. Results from these three tumor-cell lines are similar to that obtained from U251 cell line. There was no difference between D2 and D1 + D2 groups for the cell numbers of these tumor cells. Representative results of these cell lines with an interval of 12 hr between D1 and D2 were given in Fig. 2 . The results for other time intervals were not shown.
Effect of LDR on tumor growth in vivo
To validate the effects of LDR on tumor cells observed in vitro studies to an in vivo condition, we have implanted human-originated U251 and NCI-H446 tumor cells into nude mice to produce tumor-bearing animal models. When implanted tumors grow to about 0.6 cm in length, seventy tumor-bearing mice with U251 or NCI-H446 tumor cells were divided into four groups, sham group (Control), D1 group (single 75 mGy of X-rays only), D2 group (single 4 Gy of X-rays only) and D1 + D2 groups (D1 plus D2 at 12, 24, 48 or 72 hr interval). There were ten mice for each experimental condition. At beginning of the experiments (i.e. day 0), tumor weights were similar in all groups of tumorbearing mice either with U251 tumor cells or with NCI-446 tumor cells, but with increasing the post-radiation times tumor weights were gradually increased in control group (Fig. 3, left panel) . Tumor weights in D1 groups were not different from those in control from day 5 to day 20 after radiation; however, exposure of these tumor-bearing mice to D2 attenuated the tumor weight increase at day 20 after radiation as compared to control or D1 group. More interestingly, tumor weights in D1+D2 groups were not different from or slightly low as compared to that in D2 alone.
Tumor inhibition was evaluated as its percentage of reduced tumor weight on day 20 after D2 radiation when animals were sacrificed. Results, presented in Fig. 3 (right panel), show a slight (NCI-H446 tumor bearing model) and significant (U251 tumor-bearing model) enhancement of tumor inhibition effect in D1 + D2 groups as compared to D2 alone.
Although LDR did not induce radioadaptive response in the tumor cells of tumor-bearing model using nude mice, whether this phenomenon can be duplicated in the tumor cells of tumor-bearing model using normal mice remains unclear. Therefore, Kunming mice were implanted with ascites sarcoma S180 cells that were originally derived from mouse. These tumor-bearing mice were pre-irradiated with 50, 75 and 100 mGy of X-rays (D1) at 12 or 24 hr prior to 10 Gy of whole-body X radiation (D2). On day 20 after D2, mice were sacrificed and tumor inhibition was evaluated (Fig. 4) . It is clearly shown that pre-exposure to D1 significantly enhanced the tumor killing effects of D2. This study suggests that the lack of LDR-induced radioadaptive response in tumors cells was observed in the tumor-bearing mouse models not only using nude mice, but also using normal Kunming mice.
Effect of LDR on cell death and cell death-related gene and protein expressions in tumor cells in vivo
To explore the possible mechanisms by which LDR does not induce the adaptive response of tumor cells to subsequently D2-induced cell growth inhibition, apoptotic cell death and expression of apoptotic cell death-related proteins in vivo in response to D1 and D2 radiation were examined
Fig. 2. Effects of LDR on radiation-induced cytotoxic effect.
Three tumor cell lines were irradiated with 75 mGy of X-rays as D1 and then with 4 Gy of X-rays as D2 at a 12-hr interval. After D2, these cells were further incubated and harvested at different times as indicated, to count the total cells in the culturing dishes. The data are presented as described in Fig. 1. in the implanted tumor tissues of U251 and NCI-H446. TUNEL staining showed that exposure to D2 radiation significantly increased TUNEL-positive cells, and pre-exposure to D1 further enhanced D2-induced TUNEL-positive cells in both U251 and NCI-H446 tumor cells (Figs. 5 and 6) . The difference between U251 and NCI-H446 cells for the enhanced magnitude of D2-induced apoptotic effects was consistent with the difference for tumor inhibition, i.e.: the more pre-exposure of tumor-bearing mice to D1 enhanced D2-induced tumor inhibition (Fig. 3) , the higher pre-exposure of mice to D1 enhanced D2-inudced apoptotic cell death (Fig. 6) .
Since p53 and Bcl2 family members play important roles in radiation-induced apoptotic cell death, changes of p53, Bcl2 and Bax mRNA expressions were examined in the tumor cells in vivo exposed to different conditions of radiation by in situ hybridization staining for the tumor tissues (Fig. 7) . Semi-quantitative analysis of the p53 mRNA staining showed that D1 alone did not significantly affect these mRNA expressions, but slightly or significantly enhanced D2-increased p53 mRNA expression and D2-decreased Bcl2 mRNA expressions in both U251 (Fig. 8A) and NCI-H446 tumor tissues (Fig. 9A) . Results also showed that Bax mRNA expression was significantly increased in both D2 alone and D1 + D2 groups, and there was slight or significant increase for the Bax mRNA expression in D1 + D2 groups as compared to D2 alone in both U251 (Fig. 8A) and Fig. 3 . Effect of LDR on D2 therapy in tumor-bearing nude mouse models. Using nude mice, two tumor-bearing models with either U251 tumor cells or NCI-H446 tumor cells were produced and when the size of tumors reached to about 0.6 cm (long diameter) these mice were sham-irradiated or irradiated in whole-body with either 75 mGy of X-rays as D1, 4.0 Gy of X-rays as D2 or both at indicted interval times as D1 + D2. Tumor weight was calculated by the equation described in the Materials and Methods on day 0 (before irradiation) and 10 and 20. The tumor inhibition (%) was also calculated as described in Materials and Methods on day 20 when these mice were killed. The data are presented as mean ± SD from 7 -10 mice. *, p < 0.05 vs corresponding controls; #, p < 0.05 vs corresponding D2. Fig. 4 . Effect of LDR on D2 therapy in tumor-bearing Kunming mouse model. Kunming mice were implanted with mouse S180 tumor cells and irradiated with 50, 75 and 100 mGy of X-rays as D1, and 12 hr late irradiated with 10.0 Gy of γ-rays as D2. The tumor inhibition (%) was calculated on day 20 when these mice were killed, as described in Fig. 3 . The data are presented as mean ± SD from 7 -10 mice. *, p < 0.05 vs corresponding controls; #, p < 0.05 vs corresponding D2. NCI-H446 tumor tissues (Fig. 9A) .
Furthermore, the expression of Bcl2 and Bax at protein levels was also examined by immunohistochemical staining (images of these staining were not shown). Semi-quantitative analysis of Bcl2 and Bax protein expressions from U251 and NCI-H446 tumor tissues was presented in Fig. 8B and Fig.  9B , respectively, showing that Bcl2 and Bax protein levels were similar to the profiles of their mRNA expressions in both kinds of tumor cells, shown in Fig. 8A and Fig. 9A .
DISCUSSION
We have extensively demonstrated the induction of radioadaptive response by LDR in normal cell lines and tissues including cultured lymphocytes, splenocytes, thymocytes, bone marrow cells, and germ cells. 2, 4, 6, [14] [15] [16] The present study demonstrated that LDR does not induce the radioadaptive response in several tumor cell lines in vitro. More importantly, the in vitro finding was validated under an in vivo condition using three tumor-bearing animal models. We further demonstrated that cell death and cell death-related genes such as p53, Bax significantly increased, and Bcl2 decrease in D1 + D2 groups; therefore, the lack of induction of radioadaptive response in tumor cells in vivo may be related to the increase in apoptotic effect in D1 + D2 group.
Park et al. 11) have observed the lack of adaptive response induced by LDR in tumor cells. They demonstrated that the adaptive response could be induced by pretreatment with LDR in normal cells, but not in neoplastic cells. Cell lines used in this experiment include mouse lymphocytes (NL); mouse connective tissue cell line (L929); primary mouse keratinocytes (PK); mouse skin papilloma cell line (308), and X-ray sensitive lymphoma cells (L5178Y-S and EL-4). Adaptive response for cell survival and apoptosis was induced by pretreatment with LDR at 10 mGy in normal cells such as NL, L929, and PK, but not in tumor cells such as L5178Y-S, EL-4, and 308 cells. Similar results were found using PK, cancer-prone cells [v-rasHa-transfected mouse keratinocytes (ras-PK), and line 308 cells exposed to D1 at 100 mGy, and D2 at 4 Gy of γ-rays with an interval of 4 or 7 hr. 9) D1 pretreatment significantly decreased D2-induced cell death as an adaptive response prominent in normal cells (PK cells), and much less in tumor cells (ras-PK and 308 cells). Although the aforementioned results have revealed the lack of adaptive response induced by LDR in tumor cells as compared to normal cells and tissues, controversial results were also documented. 10, 12) For instance, a more recent study showed the absence of LDR-induced adaptive response in all used cell lines: one normal and three tumor cell lines.
12) Our present study is partially consistent and partially inconsistent with the above conclusion. Our study supports that LDR is unable to induce radioadaptive response in tumor cells, but does not support that LDR is also unable to induce radioadpative response in normal cell line. However, the selection of V79 cell line as the normal cell line in that study 12) may be a mistake since this cell line is no longer normal diploid cells and has been indicated the less or lack of adaptive response induced by LDR in previous studies. [17] [18] [19] A novelty of the present study is to further provide the evidence that LDR also does not induce radioadaptive response in tumor cells under the in vivo condition using tumor-bearing tumor models. We also further demonstrated an increase in apoptotic cell death in both kinds of tumor cells, examined on day 20 after D2 radiation (Fig. 6) . In a study of Schaffer et al. 20) HCV29 (human bladder epithelium) and RT4 (human bladder carcinoma) cell lines displayed opposite effects after exposed to LDR. In response to 50 or 100 mGy, HCV29 cells showed an induced radio-resistance (adaptive response), whereas the RT4 cells clearly showed an induced hyperradiosensitivity (no adaptive response). This is also consistent with the finding from Chen et al. 21) showing an enhanced apoptotic cell death of MOLT-4 cells in response to LDR given 12 hr prior to a challenge dose of 5 Gy. Therefore, these studies seems indicate that in most (Fig. 3 and Fig. 4) .
Regarding the possible mechanisms responsible for the difference in the induction of radioadaptive response by LDR between normal and tumor cells, Hendrikse et al. 22) have investigated the effect of LDR to induce an adaptive response using TK6, a lymphoblast cell line with wild-type p53, and U937, a monocytic leukemia cell line with mutant, inactive p53. In TK6 cells, LDR exposure induced elevated p53 and p21 levels and delayed expression of cyclin B1 along with an adaptive response with respect to micronuclei, while in U937 cells LDR exposure did not change these parameters and also did not induce adaptive response. This study seems to indicate the importance of p53 expression in determining LDR-induced adaptive response. In consistent with this finding, the tumor cells used in the present study included three tumor cell lines (HL-60, K562 and U251 cells) with mutant or inactivate p53 expression, [23] [24] [25] although the status of p53 expression in the rest two tumor cell lines (NCI-H446 and S180) was unclear now. In contrast, MRC-5 cells were reported to have wild-type p53 expression. 26) However, there were also documentations that do not support the importance of p53 in the induction of radioresistance by LDR. Seong et al. 27) demonstrated that whether LDR can induce a radio-resistance or sensitization in the tumor cells implanted in mice is independent on p53 expression and may be related to the changes of Bcl2 family members. In line with the latter study, our present study showed that LDR significantly enhanced D2-induced inhibition of Bcl2, an anti-apoptotic mechanism, but did not significantly affect Bax expression, a pro-apoptotic mechanism (Fig. 8,  9 ). Therefore, the increased late apoptotic cell death in the both kinds of tumor cells implanted in mice may be related to the enhancement of D2-induced inhibition of Bcl2 expression by LDR in the present study.
The lack of adaptive response in tumor cells in vitro and in vivo may also be related to other mechanisms. Lee et al. 9) demonstrated that LDR pretreatment significantly induce the translocation of PKCdelta in normal PK cells along with an adaptive response, but not in tumor ras-PK or 308 cells. Thus, the difference in the induction of radio-adaptive responses between mouse normal and neoplastic epidermal cells reflects a difference in the rapidity of cell death, and responsiveness of PKC may also affect the induction of adaptive response by LDR.
It has been documented that exposure of tumor-bearing mice to LDR might enhance immune response to suppress tumor cell proliferation. 3, 28) For example, whole-body exposure of tumor-bearing mice to LDR, once before tumor cell implantation, [28] [29] [30] or both before and after tumor cell implantation, 29, 31) significantly suppressed tumor growth as compared to those without LDR. Whole-body exposure to LDR once after tumor cell implantation also significantly suppressed the incidence of lung and lymph node metastasis. 32) These inhibitions of tumor growth and metastasis are known mainly due to the action of cellular immune reactions. [28] [29] [30] [31] 33) To support this notion, the present study showed that the increased tumor inhibition of D1 + D2 group related to D2 alone was more significant in Kunming mice (Fig. 4) than that in nude mice (Fig. 3) . This is because in Kunming mice a suppressive effect of LDR-stimulated immune reactions on tumor growth is inclusive, while in the nude mice without thymus gland, there is lack of LDRinduced immune response on tumor growth due to the reduced T cells.
In addition, one may find that the results showed that the proliferation of tumor cells in vitro under D1 + D2 irradiation was similar to that of D2 alone (Fig. 1 & Fig. 2 ), but the proliferation of tumor cells in vivo under D1 + D2 was significantly lower than that under D2. This is because in vitro results are predominant the direct effect of the radiation on tumor cells while in vivo results should include both direct effects and indirect effects of radiation on tumor cells. This assumption is supported by the fact that tumor inhibition in C57BL mouse tumor-bearing model under D1 + D2 (Fig. 4) was significantly higher than that in nude mouse tumorbearing model under D1 + D2 (Fig. 3) since C57BL mice have the normal immunological functions, including both T and B cells, while nude mice do not have T cell immune function but may have other defense functions such as B cell and hormone immune.
In summary, if combined our and other previous studies that have extensively showed the induction of adaptive response by LDR in normal tissues such as bone marrow cells, splenocytes, thymocytes, lymphocytes and germ cells, 2, 4, 6, 15, 16) we may conclude that LDR most likely induces adaptive response in normal cells in vitro and in vivo, but may not induce such response in tumor cells in vitro and in vivo. Although inconsistent results remains existence and detail mechanisms remain to be further investigated, the fact that there are different profiles for the induction of radioadaptive response by LDR between normal and tumor tissues has a greatly clinical relevance: an approach that induces the protection in normal cells, but not in tumor cells against radiotherapeutic effect, may be considered to be developed. In such case, exposure to LDR can be used prior radiotherapy to enhance the cytotoxic effect on tumor cells and to enhance the resistance to radiotherapy in normal tissues. Since 75 mGy of X-rays as LDR is able to stimulating bone marrow stem cells 34) and also a tolerant dose for patients, 35) the potentially clinical application needs be directly explored in the near future.
